In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018; we furnish hereunder certificate dated 01st April,2026 received from the SEBI registered RTA ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fredun Pharmaceuticals has submitted a routine quarterly compliance certificate to BSE under SEBI Regulation 74(5) for the quarter ended 31st March 2026. The certificate was issued by their Registrar and Transfer Agent, Purva Sharegistry (India) Pvt. Ltd., confirming that share certificates received for dematerialization during the quarter were properly processed, confirmed to the depositories, and the depositories' names were substituted in the register of members. Only two dematerialization requests were recorded during the quarter, totaling 1,000 shares (500 each from shareholders Nikhil Vora and Sheela Vora) on 9th February 2026.
This is a routine regulatory compliance filing with no material impact on the stock or shareholders. It simply confirms that the company's share dematerialization process is functioning as required by SEBI regulations.